Cencora, Inc.

COR Healthcare Medical Distribution

Cencora, Inc.’s revenue for fiscal 2026 (year ended September 2026) was $337.4 billion, up 5.00% from fiscal 2025.

Revenue
+5.52%
EPS
+258.4%
Free cash flow
−7.81%
Total debt
+47.1%

Quarter to September 2026, against a year earlier

335.94 3.74 −1.10%
Market cap
$64.8B
P/E
18.8×
Fwd P/E
17.5×
Dividend yield
0.71%
F-score
7/9
Altman Z
n/a
Beneish M
−2.59
Dividend safety
70/100
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 Sep '18 Sep '17
P/E ratio
16.64 38.97 29.69 20.80 16.63 15.97 0.00 20.23 12.21 43.84
Piotroski F-Score
7 6 7 6 5 5 5 8 6 6
P/S ratio
0.17 0.19 0.15 0.14 0.12 0.11 0.10 0.10 0.12 0.12
Altman Z-Score
— 4.83 4.89 4.65 4.65 4.11 4.17 5.07 5.01 4.77
Altman Z″-Score (non-manufacturers)
— 0.06 (0.15) (0.14) 0.00 0.09 (0.88) 0.39 0.33 0.02
P/FCF ratio
14.76 18.89 14.91 10.50 12.78 11.04 10.59 8.50 18.67 17.53
Beneish M-Score
(2.59) (2.54) (2.53) (2.51) (2.67) (2.10) (3.32) (2.64) (2.30) (2.61)
P/Operating CF
18.47 19.33 44.66 19.85 24.23 24.36 15.28 25.72 30.38 13.18
Dividend Safety Score
70 74 — — — — — — — —
P/B ratio
17.69 34.67 56.79 54.43 395.84 42.09 0.00 5.78 6.63 8.81
EV/Sales
0.19 0.20 0.16 0.15 0.13 0.13 0.10 0.10 0.13 0.13
EV/EBITDA
15.49 17.28 13.94 11.58 9.92 9.91 0.00 11.45 11.12 13.10
EV/FCF
16.41 19.92 15.32 11.14 13.83 12.89 10.34 9.05 20.67 18.84
Current Ratio
0.94 0.90 0.88 0.88 0.91 0.94 0.98 0.95 0.93 0.91
Net Debt/EBITDA
1.62 0.89 0.38 0.66 0.75 1.43 0.11 0.70 1.08 0.91
Debt/Equity
3.06 4.38 5.58 7.19 80.01 11.44 (4.91) 1.50 1.53 1.84
ROE
0.00% 122.67% 207.72% 473.26% 518.18% (1,206.73%) (316.56%) 28.31% 64.85% 17.38%
ROA
4.26% 2.16% 2.33% 2.93% 2.98% 3.03% (8.17%) 2.23% 4.54% 1.06%
ROIC
24.40% 32.52% 66.57% 51.12% 61.99% 31.17% 0.00% 16.90% 17.29% 19.36%
Return on Tangible Assets
(391.32%) (51.08%) (34.47%) (44.78%) (96.90%) (391.77%) (495.87%) 266.24% (2,000.59%) (50.84%)
Average Days of Receivables
28.49 28.65 29.64 29.22 28.49 31.37 27.55 25.19 24.59 24.56
Earnings Yield
6.01% 2.57% 3.37% 4.81% 6.01% 6.26% (17.26%) 4.94% 8.19% 2.28%
Free Cash Flow Yield
6.77% 5.29% 6.71% 9.52% 7.82% 9.06% 9.44% 11.76% 5.36% 5.70%
Free Cash Flow per Share
20.09 16.55 15.10 17.05 10.59 10.82 9.15 9.68 4.97 4.75
Book value per Share
19.06 9.01 3.96 3.29 0.34 2.84 (4.10) 14.24 14.00 9.45
Free Cash Flow
3,880.67 3,207.14 2,997.51 3,452.98 2,206.77 2,228.37 1,873.73 2,035.10 1,083.08 1,037.74
EV/EBIT
16.20 24.30 21.12 16.43 12.90 12.21 0.00 16.57 15.51 18.44
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026